Intrinsic Value

Fate Therapeutics, Inc. (FATE)


+0.57 (+2.80%)

Enterprise Value -141,331.90
Net Debt -18.77
Equity Value -141,313.14
Shares Outstanding 82.39
Equity Value Per Share -1,715.27

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt